Chemotherapy: Open Access : Citations & Metrics Report
Articles published in Chemotherapy: Open Access have been cited by esteemed scholars and scientists all around the world. Chemotherapy: Open Access has got h-index 12, which means every article in Chemotherapy: Open Access has got 12 average citations.
Following are the list of articles that have cited the articles published in Chemotherapy: Open Access.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
18 | 36 | 28 | 30 | 8 | 0 | 17 | 24 | 52 | 34 | 23 | 18 | 27 |
Research, Review articles and Editorials |
0 | 9 | 7 | 20 | 5 | 0 | 13 | 17 | 22 | 18 | 18 | 16 | 27 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
14 | 26 | 21 | 5 | 3 | 0 | 4 | 7 | 24 | 14 | 4 | 2 | 0 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28 | 0 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
36 | 53 | 100 | 85 | 112 | 83 | 142 | 208 | 141 | 51 | 22 | 53 | 3 |
| Journal total citations count | 709 |
| Journal impact factor | 1.81 |
| Journal 5 years impact factor | 3.80 |
| Journal cite score | 4.89 |
| Journal h-index | 12 |
| Journal h-index since 2019 | 9 |
Important citations (402)
joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review. |
|
tripathi s, madan a. biomarkers role in breast cancer treatment-a review. |
|
katsuta e, rashid om, takabe k. murine breast cancer mastectomy model that predicts patient outcomes for drug development. journal of surgical research. 2017;219:310-8. |
|
katsuta e, yan l, nagahashi m, raza a, sturgill jl, lyon de, et al. doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer. journal of surgical research. 2017;219:202-13. |
|
joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review. |
|
tripathi s, madan a. biomarkers role in breast cancer treatment-a review. |
|
che r. fanconi anemia signaling: the role of fancd2 during m phase. university of hawaiÊ»i at mÄnoa. |
|
joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review. |
|
tripathi s, madan a. biomarkers role in breast cancer treatment-a review. |
|
han b, shen y, zhang p, jayabal p, che r, zhang j, yu h, fei p. overlooked fancd2 variant encodes a promising, portent tumor suppressor, and alternative polyadenylation contributes to its expression. oncotarget. 2017;8(14):22490. |
|
che r, zhang j, nepal m, han b, fei p. multifaceted fanconi anemia signaling. trends in genetics. 2018;34(3):171-83. |
|
anitha sri s, prudhvi raj p. incidence and prevalence of breast cancer in usa. biochem mol biol lett. 2017;2(1):102. |
|
mamatha m. an overview of menopausal hormone replacement therapy (mhrt). |
|
tripathi s, madan a. biomarkers role in breast cancer treatment-a review. |
|
azad ma. journal of medical and health sciences. |
|
shatadru b. stem cell research: an overview. biochem mol biol lett. 2017;3(2):121. |
|
tripathi s, madan a. biomarkers role in breast cancer treatment-a review. |
|
akira hara, hiroyuki tomita, yuichiro hatano. 1. research overview pathological research covers a wide range of areas, from basic genetics to clinical pathology using human specimens. in addition to continuing research on pathological research from the onset of tumors to prevention, which is the traditional main theme of the classroom, we are also conducting research in new pathology fields related to regenerative medicine and stem cell medicine. international immunopharmacology. 2015; 28: 836-40. |
|
anitha sri s, prudhvi raj p. incidence and prevalence of breast cancer in usa. biochem mol biol lett. 2017;2(1):102. |
|
mamatha m. an overview of menopausal hormone replacement therapy (mhrt). |
|